welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Surgical Treatment of Familial Adenomatous Polyposis with an Open Technique. Experience of a Third Level Latin Ameri...INTRODUCTION : The ileal pouch-anal anas...
-
Proctocolectomy for Ulcerative Colitis or Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=zlxBwxKX...
-
Procedure for Construction of an IPAAhttps://o.quizlet.com/jDNbvWUyQJxevMasMm...
-
Ostomy Nutrition GuideThis handout is designed to help answer...
-
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisBACKGROUND : Patients with familial aden...
-
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal DiseaseThis study is being done to evaluate sin...
-
Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisRATIONALE: Exisulind may be effectiv...